down arrow

Indoco Remedies

26
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE873D01024
  • NSEID: INDOCO
  • BSEID: 532612
INR
232.20
6.7 (2.97%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 17.39 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Indoco Remedies Cash flow Statement
Figures in Rs cr
Consolidated Cash Flow Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Profit Before Tax
124.00
192.00
236.00
132.00
28.00
-9.00
Adjustment
137.00
120.00
87.00
109.00
99.00
89.00
Changes In working Capital
-87.00
-73.00
-108.00
-139.00
-1.00
55.00
Cash Flow after changes in Working Capital
174.00
240.00
214.00
101.00
126.00
135.00
Cash Flow from Operating Activities
156.00
178.00
173.00
82.00
122.00
132.00
Cash Flow from Investing Activities
-433.00
-208.00
-121.00
-66.00
-55.00
-103.00
Cash Flow from Financing Activities
280.00
22.00
-44.00
-29.00
-63.00
-16.00
Net Cash Inflow / Outflow
3.00
-6.00
8.00
-14.00
2.00
12.00
Opening Cash & Cash Equivalents
10.00
17.00
9.00
23.00
20.00
8.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
0.00
0.00
0.00
0.00
0.00
0.00
Closing Cash & Cash Equivalent
14.00
10.00
17.00
9.00
23.00
20.00
Compare Cash Flow Results of Indoco Remedies
Markets Mojo
Figures in Rs cr
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Profit Before Tax
124.27
2399.36
-2,275.00
-94.82%
Adjustment
137.55
212.2
-75.00
-35.18%
Changes In working Capital
-87.16
20.42
-107.00
-526.84%
Cash Flow after changes in Working Capital
174.66
2631.98
-2,457.00
-93.36%
Cash Flow from Operating Activities
156.7
2152.45
-1,996.00
-92.72%
Cash Flow from Investing Activities
-433.2
-2080.52
1,647.00
79.18%
Cash Flow from Financing Activities
280.43
5.27
275.00
5221.25%
Net Cash Inflow / Outflow
3.93
77.19
-74.00
-94.91%
Opening Cash & Cash Equivalents
10.92
304.82
-294.00
-96.42%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
0
0
0.00
0.00%
Closing Cash & Cash Equivalent
14.86
382.01
-368.00
-96.11%
Cash Flow - Snapshot (Consolidated) - Mar'24
stock-summary

YoY Growth in year ended Mar 2024 is -12.37% vs 2.88% in Mar 2023

Mar'24
Mar'23
Change(%)
Cash Flow from Operating Activities
156.70
178.83
-12.37%